BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25407057)

  • 1. Handling missing data in RCTs; a review of the top medical journals.
    Bell ML; Fiero M; Horton NJ; Hsu CH
    BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals.
    Wood AM; White IR; Thompson SG
    Clin Trials; 2004; 1(4):368-76. PubMed ID: 16279275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the intention-to-treat principle in nursing clinical trials.
    Polit DF; Gillespie BM
    Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.
    Khan NA; Torralba KD; Aslam F
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34330848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data.
    Tan PT; Cro S; Van Vogt E; Szigeti M; Cornelius VR
    BMC Med Res Methodol; 2021 Apr; 21(1):72. PubMed ID: 33858355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade?
    Fielding S; Ogbuagu A; Sivasubramaniam S; MacLennan G; Ramsay CR
    Qual Life Res; 2016 Dec; 25(12):2977-2983. PubMed ID: 27650288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intention to treat (ITT) analysis as reported in orthodontic randomized controlled trials-evaluations of methodology and recommendations for the accurate use of ITT analysis and handling dropouts.
    Bondemark L; Abdulraheem S
    Eur J Orthod; 2018 Jul; 40(4):409-413. PubMed ID: 29069355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intention-to-treat analysis: Are we managing dropouts and missing data properly in research on orthodontic treatment? A systematic review.
    Barretto Dos Santos Lopes Batista K; Thiruvenkatachari B; O'Brien K
    Am J Orthod Dentofacial Orthop; 2019 Jan; 155(1):19-27.e3. PubMed ID: 30591159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.
    Ibrahim F; Tom BD; Scott DL; Prevost AT
    Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature.
    Alshurafa M; Briel M; Akl EA; Haines T; Moayyedi P; Gentles SJ; Rios L; Tran C; Bhatnagar N; Lamontagne F; Walter SD; Guyatt GH
    PLoS One; 2012; 7(11):e49163. PubMed ID: 23166608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review.
    Fiero MH; Huang S; Oren E; Bell ML
    Trials; 2016 Feb; 17():72. PubMed ID: 26862034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disentangling estimands and the intention-to-treat principle.
    Leuchs AK; Brandt A; Zinserling J; Benda N
    Pharm Stat; 2017 Jan; 16(1):12-19. PubMed ID: 27910217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases.
    Baron G; Boutron I; Giraudeau B; Ravaud P
    Arthritis Rheum; 2005 Jun; 52(6):1858-65. PubMed ID: 15934058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss to analysis in randomized controlled trials in CKD.
    Deo A; Schmid CH; Earley A; Lau J; Uhlig K
    Am J Kidney Dis; 2011 Sep; 58(3):349-55. PubMed ID: 21778004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.